A certain amount of blood pressure medication was recalled after a bottle of this lot was labeled as incorrect, according to a statement by the Food and Drug Administration (FDA).
The bottle should contain hydrochlorothiazide tablets USP 12.5 mg, a drug used to treat high blood pressure, instead contained USP 25 mg spironolactone tablets – used to treat congestive heart failure, cirrhosis, and other diseases.
The FDA says that the effects of mixing the drugs on the
Accord Healthcare Inc. voluntarily recalled a single batch of the drug PW05264 after research revealed that it was the only potentially affected batch.
Accord & # 39 ; s hydrochlorothiazide tablets USP 12.5 mg can be identified by a visual Leader . The tablets should be bright orange or peach-colored and round. They have an "H" and a "1" on opposite sides.
For individuals holding Accord Hydrochlorothiazide tablets that do not conform to this description, the FDA recommends that you check with a pharmacy or health care provider.
Accord says there have been no reports of adverse events related to this recall under FDA clearance.
Read or Share This story: https://usat.ly/2wmTieD